News about participation in key industry related events can almost always be a major boost for any upcoming innovative company and it is no different for Pressure Biosciences Inc (OTCQB:PBIO).
On Monday, PBIO stock gained 1.50% to $1.34 with 16K shares, compared to its average volume of 13K shares. The stock moved within a range of $1.32 – $1.35 after opening trade at $1.33.
The company, which is involved in the development of pressure-based instruments meant for usage across several industries was in the news this morning after it announced that it was going to be one of the participants at the Development of a New Generation of Skincare Products webinar that is going to be held later on in the week on October 13, 2022. The event is sponsored by the FORCE Family Office.
This is an important event for the company considering the fact that Pressure Biosciences had recently gone into a partnership with Dr. Adrienne Denese, who is regarded as a visionary and pioneer in the skincare as well as anti-ageing industries.
Denese operates through QVC and has managed to generate sales to the tune of more than $500 million over the course of its lifetime so far. At the above-mentioned event Pressure Biosciences is going to be able to showcase this new partnership in far greater detail. Dr. Denese is also going to be in attendance at the event.
However, that is not all. In this regard, it should also be noted that Pressure Biosciences is also working on its revolutionary Ultra Shear Technology.
This technology is also something that could help completely revolutionize the skincare industry and during the course of the event, the company is going to showcase this technology as well. At this point in time, it may be a good idea for investors to keep the Pressure Biosciences stock on their watch lists in the lead-up to the big event on October 13. It remains to be seen if the stock gains any major traction or not.
PBIO stock is trading below the 20-Day and 50-Day Moving averages of $0.0187 and $0.0247 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.0295.